Enoxaparin sodium biosimilar (Neiss Labs)

依诺肝素钠生物类似药 (Neiss Labs)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEnoxaparin sodium biosimilar (Neiss Labs)
Drug Alias Name依诺肝素钠生物仿制药 (Neiss Labs)Lomonox
ClassificationBiologics > Biosimilar
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsVenous Thrombosis
Global Approved IndicationsVenous Thrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/08/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNeiss Labs
China Registration ClassN/A

Develop Information

Active CompaniesNeiss Labs
Inactive CompaniesN/A
Active IndicationsVenous Thrombosis
Inactive IndicationsN/A

Other Information

ATC CodeB01AB05
Related LinksN/A